Top Markets
Coin of the day
Lifeline Biotechnologies, Inc. Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc.

LLBO
Rang in Aktien #36501
Lifeline Biotechnologies, Inc. operates as a medical technology company in the... Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Aktienkurs
$0.0006
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$2.61M
Veränderung (1 Tag)
50.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Lifeline Biotechnologies, Inc. (LLBO)

Kategorie

Kursverlauf für Lifeline Biotechnologies, Inc. (LLBO)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $4.26K am 2005-05-01
Kursverlauf der Aktie von Lifeline Biotechnologies, Inc. von 2005 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 281.82%
2024 -4.76%
2023 -45.45%
2022 -11.36%
2021 -25.96%
2020 -53.18%
2019 -58.28%
2018 41.87%
2017 110.05%
2016 -60.61%
2015 537.98%
2014 208.39%
2013 -51.45%
2012 155.00%
2011 -51.11%
2010 -93.10%
2009 -49.50%
2008 -94.53%
2007 -99.58%
2006 -98.06%
2005 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$233.13 -5.06%
IE
$15.71 -11.83%
CN
$537.65 11.36%
CH
$172.71 -8.57%
CH
$2.35 -28.05%
CN